title: Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome.
authors.forename: E
authors.initials: E
authors.lastname: del Río García
authors.forename: C
authors.initials: C
authors.lastname: Rodríguez
authors.forename: J
authors.initials: J
authors.lastname: Rodríguez-Martorell
authors.forename: A
authors.initials: A
authors.lastname: Serrano
authors.forename: J A
authors.initials: JA
authors.lastname: Girón-González
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008297:Male; D015539:Platelet Activation / Q000502:physiology*; D011446:Prospective Studies
chemical_list: D017153:Antibodies, Anticardiolipin; D016682:Lupus Coagulation Inhibitor